Comparative effectiveness of 3 or 4 doses of mRNA and inactivated whole-virus vaccines against COVID-19 infection, hospitalization and severe outcomes among …
Previous studies have found that two doses of inactivated whole-virus vaccines elicited
lower antibody titers and conferred less protection against SARS-CoV-2 infection than two …
lower antibody titers and conferred less protection against SARS-CoV-2 infection than two …
[HTML][HTML] Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccination
Nursing home (NH) residents have experienced significant morbidity and mortality to SARS-
CoV-2 throughout the pandemic. Vaccines initially curbed NH resident morbidity and …
CoV-2 throughout the pandemic. Vaccines initially curbed NH resident morbidity and …
[HTML][HTML] Determinants of early antibody responses to COVID-19 mRNA vaccines in a cohort of exposed and naïve healthcare workers
Background Two doses of mRNA vaccination have shown> 94% efficacy at preventing
COVID-19 mostly in naïve adults, but it is not clear if the second dose is needed to maximize …
COVID-19 mostly in naïve adults, but it is not clear if the second dose is needed to maximize …
Immunogenicity of BNT162b2 vaccine booster against SARS-CoV-2 Delta and Omicron variants in nursing home residents: A prospective observational study in older …
EK Alidjinou, J Demaret, B Corroyer-Simovic… - The Lancet Regional …, 2022 - thelancet.com
Background The present study aimed to evaluate the persistent immunogenicity offered by a
third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) …
third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) …
The impact of SARS-CoV-2 vaccines on antibody responses in the general population in the United Kingdom
Real-world data on antibody response post-vaccination in the general population are
limited. 45,965 adults in the UK's national COVID-19 Infection Survey receiving Pfizer …
limited. 45,965 adults in the UK's national COVID-19 Infection Survey receiving Pfizer …
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study
KF Nielsen, IR Moustsen-Helms, AB Schelde… - PLoS …, 2022 - journals.plos.org
Background Individuals with a prior Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) infection have a moderate to high degree of protection against reinfection …
(SARS-CoV-2) infection have a moderate to high degree of protection against reinfection …
[HTML][HTML] Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden
P Nordström, M Ballin, A Nordström - The Lancet, 2022 - thelancet.com
Background Vaccine effectiveness against COVID-19 beyond 6 months remains
incompletely understood. We aimed to investigate the effectiveness of COVID-19 …
incompletely understood. We aimed to investigate the effectiveness of COVID-19 …
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA. 2 wave in Geneva, Switzerland: a population-based …
ME Zaballa, J Perez-Saez, C de Mestral… - The Lancet Regional …, 2023 - thelancet.com
Background More than two years into the COVID-19 pandemic, most of the population has
developed anti-SARS-CoV-2 antibodies from infection and/or vaccination. However, public …
developed anti-SARS-CoV-2 antibodies from infection and/or vaccination. However, public …
Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign
E Meyers, L De Rop, E Deschepper… - European Journal of …, 2023 - Taylor & Francis
Background Nursing home residents (NHR) and staff have been disproportionally affected
by the COVID-19 pandemic and were therefore prioritised in the COVID-19 vaccination …
by the COVID-19 pandemic and were therefore prioritised in the COVID-19 vaccination …
Direct and indirect effectiveness of mRNA vaccination against SARS-CoV-2 infection in long-term care facilities in Spain
S Monge, C Olmedo, B Alejos, MF Lapeña, MJ Sierra… - medRxiv, 2021 - medrxiv.org
Objectives To estimate indirect and total (direct plus indirect) effects of COVID-19
vaccination in residents in long-term care facilities (LTCF). Design Registries-based cohort …
vaccination in residents in long-term care facilities (LTCF). Design Registries-based cohort …